Bayer, J&J win third U.S. Xarelto trial
More Info: Defective Drugs
A federal jury has cleared Bayer AG and Johnson & Johnson of liability in the third case to go to trial out of thousands of lawsuits claiming the drugmakers’ blood thinner Xarelto led to severe internal bleeding.
The verdict in U.S. District Court in Jackson, Mississippi, is a blow to thousands of patients with similar allegations against the drugmaker. The jury returned the verdict after just four hours of deliberation.
The companies also won the previous two trials on claims of risks from Xarelto.
In the latest case, plaintiff Dora Mingo claimed she suffered acute gastrointestinal bleeding after she was treated with Xarelto for a month in 2015 to prevent blood clotting following an operation.
She accused the drugmakers, who jointly developed the blood thinner, of having failed to warn about the bleeding risks and said her injuries could have been prevented had they provided adequate information.
See the full, original post here: https://www.reuters.com/article/us-bayer-xarelto-idUSKCN1AY2GG
TriMark Legal Funding was founded in 2003 and is one of America's original lawsuit funding companies. TriMark provides pre-settlement loans and post-settlement loans to injured plaintiffs who are involved in personal injury lawsuits, employment litigation, work injury accidents and workers compensation settlement funding, mass tort litigation, and multidistrict litigation. We also provide loans for lawyers and law firm portfolio funding.
|Mass Torts||Other MDL|
Click here to see the original article.